ERA Congress is the annual meeting of the European Renal Association (ERA).
Travere at ERA
The theme of the ERA 2025 Congress is “Game Changers in Nephrology.” Travere Therapeutics is excited to participate in the event and engage with renal healthcare professionals.
Program
Thursday, June 5
Kidney Outcomes and Effects of Proteinuria in Alport Syndrome: A Longitudinal Analysis of 1175 Patients from the UK National Registry of Rare Kidney Diseases (RaDaR)
Speakers: Katie Wong, David Pitcher, Dane Rogers, Sherry Masoud, Sascha Van Boemmel-Wegmann, Klaus Francke, Julie Lin, Shiguang Liu, Hannah Russell, Susie Gear, Alex Mercer, Bruce Hendry, A. Neil Turner, Daniel P. Gale
Session: Hall K
Type: Poster
Time: 4:54 PM – 5:06 PM CEST
Meet a Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Schedule a meetingPopulation Modelling Depicts the Mutational Burden of NPHS2 (podocin) Nephropathy and Reveals an Undiagnosed Later Onset Genetic Cohort
Speakers: Wen Ding, Karen Malone, Dinah Clark, Radko Komers, Pille Harrison, Fredrik Erlandsson, Moin Saleem
Session: Focused oral room 1
Type: Presentation
Time: 03:00 PM – 03:06 PM CEST
Sparsentan Reduces Glomerular Dysfunction and Proteinuria in a Rat Model of Serum-Factor-Induced Nephrotic Syndrome
Speakers: Michael Crompton, Holly Stowell-Connolly, Jack Mills, Viktoriia Vasylchenko, Celia P. Jenkinson, Bruce Hendry, Radko Komers, Hiroshi Kawachi, Matthew Butler, Gavin Welsh, Rebecca R. Foster, Simon C. Satchell
Session: Wall 1 Mozart Eine Kleine Nachtmusik
Type: Poster
Time: 09:48 AM – 09:51 AM CEST
Sparsentan Reversibly Decreases Mesangial IgA Deposition in gddY Mice; a Possible Role for Mesangial-Cell-Surface Autoantigen Expression
Speakers: Kazuaki Mori, Yoshihito Nihei, Celia Jenkinson, Bruce Hendry, Hitoshi Suzuki, Yusuke Suzuki
Session: Focused oral room 2
Type: Presentation
Time: 08:33 AM – 08:39 AM CEST
Effects of Sparsentan After Maximized Angiotensin Receptor Blocker (ARB) Treatment in Patients With IgA Nephropathy (IgAN) in the PROTECT Trial
Speakers: Jürgen Floege, Dana V. Rizk, Priscila Preciado, Brad Rovin, Stephanie Moody, Rob Geletka, Alex Mercer, Bruce Hendry, Radko Komers, Vladimir Tesar
Session: Focused oral room 2
Type: Presentation
Time: 09:05 AM – 09:10 AM CEST
Friday, 6 June
Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors in Adults With IgA Nephropathy in the Phase 2 SPARTACUS Trial
Speakers: Sydney Tang, Isabelle M. Ayoub, Laura Kooienga, Priscila Preciado, David Lee, Radko Komers, Bruce Hendry, Alex Mercer, Stephanie Moody, Brad Rovin
Session: Focused oral room 3
Type: Presentation
Time: 09:00 AM – 09:05 AM CEST
Patients With Focal Segmental Glomerulosclerosis (FSGS) Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan (SPAR) vs Irbesartan (IRB) in DUPLEX
Speakers: Vladimir Tesar, Hernan Trimarchi, James Tumlin, Laura Kooienga, Radko Komers, Jula Inrig, Edward Murphy, Eva Rodríguez García
Session: Focused oral room 2
Type: Presentation
Time: 04:40 PM – 04:45 PM CEST
MA-DS-25-0003 | May 2025